Facial Injectable Market Size Estimated to Surge USD 33.56 Billion Growth by 2032, Exhibit a CAGR of 12.6% | PMR

𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐚𝐜𝐢𝐚𝐥 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐢𝐬 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟏𝟏.𝟔𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐚𝐧 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 𝟑𝟑.𝟓𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐬𝐭𝐮𝐝𝐲 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡. 𝐁𝐞𝐬𝐢𝐝𝐞𝐬, 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐬 𝐚 𝐫𝐨𝐛𝐮𝐬𝐭 𝟏𝟐.𝟔% 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞, 𝟐𝟎𝟐𝟒 - 𝟐𝟎𝟑𝟐

The high rate of FDA approvals for new facial injectables is one of the major factors propelling the industry forward. Besides, the surging adoption of facial injectables among the male population is supporting the development of the market. Facial injectable, also referred to as injectable filler, is a soft tissue filler that's made of polysaccharides. These fillers are injected into the skin at various depths to pump up wrinkles and smooth lines on your face.

𝐂𝐥𝐢𝐜𝐤 𝐭𝐨 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐝 𝐃𝐫𝐢𝐯𝐞 𝐈𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬:
https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-sample

Also, they help in providing facial volume and augmenting facial features. There are many types of facial injectables, including hyaluronic acid, calcium hydroxyapatite, poly-L-lactic acid, and polymethyl methacrylate. Hyaluronic acid is a naturally occurring acid in the skin that keeps the skin hydrated. Calcium hydroxyapatite contains substances present in the bones, whereas poly-L-lactic acid helps the body create its own collagen.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The facial injectable market is fragmented in nature. The market has the presence of both established players and new entrants. These players focus on new partnerships and collaborations to maintain a competitive edge in the industry. Some of the major players operating in the market include:

• Allergan Aesthetics (AbbVie Inc.) (U.S.)
• BIOPLUS CO., LTD. (Korea)
• Bioxis Pharmaceuticals (France)
• GALDERMA (Switzerland)
• Ipsen Pharma (France)
• Merz Pharma (Germany)
• Medytox (South Korea)
• Prollenium Medical Technologies (Canada)
• Revance Therapeutics, Inc. (U.S.)
• Sinclair (Huadong Medicine Co., Ltd.) (UK)
• Teoxane (Switzerland)
• Zimmer Aesthetics (Germany)

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

𝐅𝐚𝐜𝐢𝐚𝐥 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞, 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)
• Collagen & PMMA Microspheres
• Botulinum Toxin Type A
• Hyaluronic Acid (HA)
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

𝐅𝐚𝐜𝐢𝐚𝐥 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞, 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)
• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

𝐅𝐚𝐜𝐢𝐚𝐥 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞, 𝐄𝐧𝐝-𝐮𝐬𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)
• MedSpa
• Dermatology Clinics
• Hospitals

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

• The North America region dominated the market with the largest revenue share in 2022. This can primarily be attributed to new product launches and a high rate of FDA approvals. Besides, the large proportion of women with high discretionary income is further supporting the market's development in the region.

• The Asia Pacific region is anticipated to grow at a rapid pace over the estimated period. This is largely due to the increasing disposable income and growing medical tourism for aesthetic procedures in low-cost APAC nations.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐰𝐢𝐭𝐡 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/buy/139/2

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐆𝐫𝐨𝐰𝐭𝐡:

• Growing Demand for Non-Surgical Aesthetic Procedures: There is a rising trend towards non-surgical cosmetic treatments as patients seek natural-looking results with minimal downtime. Facial injectables offer a convenient and effective solution for individuals looking to refresh their appearance without undergoing invasive surgery.

• Technological Advancements and Product Innovation: Ongoing advancements in injectable technology and formulation techniques have led to the development of next-generation products with improved safety, longevity, and patient satisfaction. New formulations and delivery methods enhance product performance while minimizing side effects and discomfort.

• Aging Population and Beauty Consciousness: The aging population, coupled with increasing beauty consciousness, drives demand for facial injectables as individuals seek to maintain a youthful appearance and address age-related concerns. Social media influence and celebrity endorsements further contribute to the popularity of aesthetic treatments.

• Expanding Market Reach and Accessibility: Facial injectables are becoming more accessible to a broader demographic, thanks to the expansion of aesthetic clinics, medspas, and dermatology practices offering injectable treatments. Moreover, flexible financing options and promotional offers make aesthetic procedures more affordable and appealing to consumers.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market

𝐅𝐚𝐜𝐢𝐚𝐥 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The Hyaluronic Acid (HA) segment will grow rapidly, attributed to its versatility, efficacy, and minimally invasive nature of the product.
• The Facial line correction segment accounted for the largest market share, owing to the rapid growth of aging population across the globe.
• The MedSpa segment dominated the market, due to the surge in demand for cosmetic procedures.
• North America dominated the market, owing to the rise in awareness related to the benefits of facial injectables.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐒𝐥𝐞𝐞𝐩 𝐀𝐩𝐧𝐞𝐚 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/sleep-apnea-devices-market

𝐋𝐞𝐠𝐚𝐥 𝐌𝐚𝐫𝐢𝐣𝐮𝐚𝐧𝐚 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/legal-marijuana-market

𝐀𝐧𝐭𝐢-𝐀𝐠𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/anti-aging-market

𝐀𝐧𝐢𝐦𝐚𝐥 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/animal-vaccines-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.